DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.

The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...

Dexcom announced today that it received a warning letter from the FDA following inspections of two company facilities.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Achieve Life Sciences (ACHV – Research Report) ...

DexCom (NasdaqGS:DXCM) recently received a warning letter from the FDA, which pointed out issues in manufacturing processes and quality management. While these regulatory developments did not impact ...

March 7 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab said it has received a warning letter from the U.S. Food and Drug Administration following inspections of its two key ...

Operating income (non-GAAP) decreased to $209.5 million from $242.7 million. DexCom reported mixed earnings, with revenue surpassing estimates but earnings per share falling short. DexCom ...

The recent selloff of U.S. equities continued at midday on fears the U.S. economy could be heading toward a recession. The Nasdaq sank 3%, the S&P 500 dipped about 2%, and the Dow Jones Industrial ...

DexCom's growth is slowing with 2024 marking the slowest growth year in a decade and 2025 expected to follow suit with ~14% ...

Private Trust Co. NA lifted its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 266.3% in the fourth ...

DexCom DXCM-2.10%decrease; red down pointing triangle received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz. facilities and is ...